| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |